We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

H:TSXHydro One Limited Analysis

Data as of 2026-05-23 - not real-time

CA$59.17

Latest Price

4/10Risk

Risk Level: Medium

Executive Summary

Hydro One is trading at CAD 59.17, comfortably above its 20‑day (58.55) and 50‑day (58.36) SMAs and riding a bullish MACD crossover with a modest RSI of 56.6, suggesting short‑term momentum remains intact. Support sits at 57.31 while the nearest resistance is near 59.61, placing the stock in a tight range that could trigger a pull‑back if sellers test the ceiling. Recent earnings beat, driven by higher rates and peak demand, and the declaration of a quarterly dividend of $0.3531 per share underscore the company’s cash‑flow resilience, yet free cash flow remains negative and debt‑to‑equity is an elevated 148 ×, flagging balance‑sheet pressure. The valuation gap is stark: a trailing P/E of 25.95 versus an industry average of 22, and a DCF‑derived fair value of only CAD 27.8, yielding a downside‑adjusted upside of –3.8 % and labeling the stock as overvalued at current levels. Despite these concerns, the regulated utility model delivers a stable 2.39 % dividend yield with a payout ratio under 60 %, supporting the case for dividend sustainability in the medium term.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bullish technicals but price near resistance
  • Overvaluation relative to DCF
  • Strong dividend yield supporting demand

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Persistent valuation gap (PE above industry)
  • High debt load and negative free cash flow
  • Regulated rate environment offering revenue stability

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Stable regulated cash flows and dividend income
  • Potential for debt reduction and cash‑flow improvement
  • Long‑term growth from infrastructure investments and Indigenous partnerships

Key Metrics & Analysis

Financial Health

Revenue Growth10.00%
Profit Margin14.78%
P/E Ratio26.0
ROE10.92%
ROA3.69%
Debt/Equity147.79
P/B Ratio2.8
Op. Cash FlowCA$2.6B
Free Cash FlowCA$-1412875008
Industry P/E22.0

Technical Analysis

TrendBullish
RSI56.6
SupportCA$57.31
ResistanceCA$59.61
MA 20CA$58.55
MA 50CA$58.36
MA 200CA$54.19
MACDBullish
VolumeStable
Fear & Greed Index91.61

Valuation

Fair ValueCA$27.83
Target PriceCA$56.93
Upside/Downside-3.79%
GradeOvervalued
TypeValue
Dividend Yield2.39%

Risk Assessment

Beta-0.25
Volatility14.17%
Sector RiskLow
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.